Skip to Content
Merck
  • Detection of liver metastases under 2 cm: comparison of different acquisition protocols in four row multidetector-CT (MDCT).

Detection of liver metastases under 2 cm: comparison of different acquisition protocols in four row multidetector-CT (MDCT).

European radiology (2005-05-04)
Amina Abdelmoumene, Patrick Chevallier, Marc Chalaron, Frédéric Schneider, Francis R Verdun, Phillipe Frascarolo, Reto Meuli, Pierre Schnyder, Alban Denys
ABSTRACT

This study compared different acquisition protocols performance to detect small liver metastases (<2 cm). Thirty consecutive patients with histologically proven hepatic metastases were explored by MDCT at the liver equilibrium phase by four successive acquisitions. We compared the following protocols (1-4): 5/30/1.5 (section thickness/table speed/pitch); 5/15/0.75; 5/11.25/0.75; and 2.5/15/1.5 with the same X-ray dose. The gold standard was based on patient radiological follow-up. Evolutive lesions were considered as true positive (TP). The described lesions, not found on the follow-up exams despite tumoral progression, were considered as false positive (FP). Stable lesions could not be considered as metastasis and were eliminated. One hundred and seventy-six lesions were detected: 61 TP and 91 FP. Twenty-four lesions were eliminated. The mean kappa values for protocols 1, 2, 3 and 4 were, respectively, 0.43, 0.68, 0.73 and 0.51 (0.61-0.80: substantial agreement) and the mean areas under the ROC curve were, respectively, 0.76, 0.87, 0.86 and 0.80. The results of protocols 2 and 3 were significantly superior to those of protocols 1 and 4. MDCT protocols using thin sections or an increased table speed are less efficient in detecting small metastases.

MATERIALS
Product Number
Brand
Product Description

USP
Iodixanol Related Compound D, United States Pharmacopeia (USP) Reference Standard
Iopentol, European Pharmacopoeia (EP) Reference Standard